News
The FDA said some of Boston Scientific ’s Endotak Reliance defibrillator wires can become calcified, which may stop the ...
US health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices.
11h
Zacks Investment Research on MSNInvestors Heavily Search Boston Scientific Corporation (BSX): Here is What You Need to KnowBoston Scientific (BSX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...
The FDA has issued an alert about a potentially high-risk issue involving models of Boston Scientific’s Watchman Access Systems, which are used to provide vascular and transseptal access during ...
A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the ...
Boston Scientific Corporation (NYSE:BSX) is one of the most profitable growth stocks to buy according to billionaires. On ...
6d
Barchart on MSNBoston Scientific Stock Outlook: Is Wall Street Bullish or Bearish?Boston Scientific has outperformed the broader market over the past year, and analysts are highly optimistic about the ...
Boston Scientific has launched Endura Weight Loss Solutions, alongside survey findings showing that many U.S. women are ...
When considering lead replacement, physicians should weigh the risks and benefits of extraction versus abandonment.
Boston Scientific warned of the potential for rising low-voltage shock impedance (LVSI) associated with Reliance ...
This was the stock's second consecutive day of gains.
The current consensus estimates for BSX's forthcoming earnings report stand at $0.72 per share on revenue of $4.89 billion.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results